This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (63)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sergei A. Grando, CandSci(Med); Boris T. Glukhenky, DSci(Med); George N. Drannik, DSci(Med); Evsey V. Epshtein, DSci(Med); Alexander P. Kostromin, DSci(Biol); Taras A. Korostash

Arch Dermatol. 1989;125(7):925-930.

Abstract
• Blister fluids from 39 previously untreated patients with pemphigus vulgaris (PV) and 28 patients with bullous pemphigoid (BP) were tested for the presence of inflammatory mediators. Blister fluids from patients with PV and BP showed interleukin 1 (IL-1)- and interleukin 2 (IL-2)-like activity and contained prostaglandin (PG) E₂, F₁, and F₂, thromboxane B₂ (TB₂), leukotriene (LT) B₄ and C₄, serine esterases, and proteolysis inhibitors. Pemphigus blister fluid was distinguished by high IL-1-like activity, proteolytic activity, and high concentrations of TB₂ and LTB₄, while pemphigoid blister fluid was characterized by higher IL-2-like activity, antiprotease activity, and high PGE₂ concentration. We also determined that the content of mediators of inflammation varied depending on the duration of blister development. In both PV and BP, the initially high IL-1-like activity, amount of serine proteases, and concentrations of PGF₂, TB,₂ LTB₄, and LTC₄ decreased by the fifth day of blister existence, whereas antiprotease activity as well as PGE₂ and PGF₁ concentrations gradually increased as blisters developed. These findings suggest certain differences in the character of the bullous inflammatory process in pemphigus and pemphigoid.

(Arch Dermatol 1989;125:925-930)

Author Affiliations
From the Unit of Immunodermatology (Dr Grando) and Chair of Dermato-Venereology (Drs Grando and Glukhenky and Mr Korostash), Kiev (USSR) State Advanced Training Institute for Doctors; Centre for Clinical and Experimental Immunology, UkrSSR Academy of Sciences and Ministry of Health, Kiev (Dr Drannik); Radioimmunology Laboratory, Kiev, Institute of Endocrinology (Dr Epshtein); and Laboratory of Immunobiology, Kiev State University (Dr Kostromin).

Footnotes
Accepted for publication Sept 15, 1988.

Reprint requests to Chair of Dermato-Venereology, KGIUV, GKVD-2, 72 Saksagansky St, Kiev-32, 252032 USSR (Dr Grando).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High Levels of Interleukin-1 in Patients with Endemic Pemphigus Foliaceus
Rocha-Rodrigues et al.
CVI 2003;10:741-743.
ABSTRACT | FULL TEXT  

Macrophages, But Not T and B Lymphocytes, Are Critical for Subepidermal Blister Formation in Experimental Bullous Pemphigoid: Macrophage-Mediated Neutrophil Infiltration Depends on Mast Cell Activation
Chen et al.
J. Immunol. 2002;169:3987-3992.
ABSTRACT | FULL TEXT  

Novel Human {alpha}9 Acetylcholine Receptor Regulating Keratinocyte Adhesion is Targeted by Pemphigus Vulgaris Autoimmunity
Nguyen et al.
Am. J. Pathol. 2000;157:1377-1391.
ABSTRACT | FULL TEXT  

Gelatinase B-deficient Mice Are Resistant to Experimental Bullous Pemphigoid
Liu et al.
JEM 1998;188:475-482.
ABSTRACT | FULL TEXT  

Pemphigus Vulgaris Antibody Identifies Pemphaxin. A NOVEL KERATINOCYTE ANNEXIN-LIKE MOLECULE BINDING ACETYLCHOLINE
Nguyen et al.
J. Biol. Chem. 2000;275:29466-29476.
ABSTRACT | FULL TEXT